Community Asthma Initiative: Cost Analyses using Claims Data from a Medicaid Managed Care Organization

Urmi Bhaumik1,2, Susan J Sommer2, Ryan Lockridge3

  • 1Office of Community Health, Boston Children's Hospital, Boston, MA, USA.

Insights

The Community Asthma Initiative (CAI), a home-visiting program, significantly reduced asthma-related healthcare costs. This nurse-supervised community health worker (CHW) intervention demonstrated a positive return on investment (ROI), proving its cost-effectiveness.

Area of Science:

  • Public Health
  • Health Services Research
  • Health Economics

Background:

  • Asthma is a significant public health concern, leading to high healthcare utilization and costs.
  • Community-based interventions are increasingly explored to manage chronic diseases like asthma effectively.
  • The Community Asthma Initiative (CAI) aimed to assess the economic impact of a home-visiting program.

Purpose of the Study:

  • To evaluate the cost-benefit of the Community Asthma Initiative (CAI), a nurse-supervised community health worker (CHW) asthma home-visiting program.
  • To determine the return on investment (ROI) of the CAI program using claims data.

Main Methods:

  • Analysis of Massachusetts Medicaid Managed Care Organization (MCO) claims data from 2011-2016.
  • Comparison of asthma-related utilization costs between 45 CAI patients and 45 cost-matched controls.
  • Calculation of ROI based on cost reductions and program expenses.

Main Results:

  • CAI patients experienced excess cost reductions of $806, $1,253, and $1,549 at 1, 2, and 3 years post-intervention, respectively.
  • Adjusted ROIs were 0.31, 0.78, and 1.37 after 1, 2, and 3 years, indicating increasing cost-effectiveness over time.
  • The reduction in asthma utilization costs surpassed the program's operational costs.

Conclusions:

  • Home-based asthma programs delivered by nurse-supervised CHWs are cost-effective.
  • Findings support integrating such secondary prevention services into payer reimbursement models or Accountable Care Organizations (ACOs).
  • The CAI program presents a strong business case for payers and healthcare systems.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.8K
What are Populations and Communities?00:30

What are Populations and Communities?

Overview
37.7K
Testing a Claim about Mean: Known Population SD01:11

Testing a Claim about Mean: Known Population SD

A complete procedure of testing the hypothesis about a population mean is explained here.
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
3.3K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K